莱伯泰科(688056) - 2023 Q3 - 季度财报

Key Financial Data Key Accounting Data and Financial Indicators In Q3 2023, the company's operating revenue increased year-over-year, but net profit attributable to shareholders and non-recurring net profit both declined significantly by approximately 70% 2023 Q3 and YTD Core Financial Indicators | Indicator | Current Period (Q3 2023) | YoY Change (Current Period) | Year-to-Date (YTD Q3 2023) | YoY Change (YTD) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (RMB) | 104,000,000 | +10.88% | 300,000,000 | +20.45% | | Net Profit Attributable to Shareholders (RMB) | 3,832,400 | -69.16% | 26,660,700 | -22.77% | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) (RMB) | 3,524,100 | -70.76% | 24,870,200 | -23.46% | | Basic Earnings Per Share (RMB/share) | 0.06 | -66.67% | 0.40 | -21.57% | | Total R&D Investment (RMB) | 15,139,200 | +53.22% | 36,857,400 | +36.71% | - As of the end of the reporting period, the company's total assets were 993 million RMB, a 3.24% increase from the end of the previous year; owner's equity attributable to listed company shareholders was 849 million RMB, a 2.71% increase from the end of the previous year[6] Non-Recurring Gains and Losses Items and Amounts Year-to-date, the company's non-recurring gains and losses totaled 1.7905 million RMB, primarily from government grants and investment income Year-to-Date Main Non-Recurring Gains and Losses Items | Item | Amount (RMB) | | :--- | :--- | | Government grants included in current profit and loss | 815,099.28 | | Fair value changes and investment income from transactional financial assets, etc. | 1,347,589.19 | | Income tax impact | -357,419.97 | | Total | 1,790,490.19 | - The company classified 1.7161 million RMB in software tax refunds as recurring gains and losses, as it is directly related to and frequently occurs in daily sales operations[11] Analysis of Changes in Key Accounting Data and Financial Indicators The company explained the significant fluctuations in key financial indicators for the current reporting period, attributing net profit decline to market and cost factors, while improved operating cash flow resulted from increased collections and reduced procurement - Q3 net profit significantly declined (-69.16%) primarily due to: - Market demand falling short of expectations and increased competition leading to lower gross profit margins[11] - Increased depreciation and property-related expenses after the new production base was put into operation[11] - Increased investment in R&D personnel and materials due to new key R&D projects[11] - Increased market promotion and marketing expenses for new products[11] - Net cash flow from operating activities turned positive year-to-date, mainly due to a 20.45% increase in revenue, a corresponding increase in cash received from sales, and sufficient prior inventory reserves leading to a lower increase in current period procurement expenditures compared to revenue growth[11] - R&D investment for the current period and year-to-date significantly increased (53.22% and 36.71% respectively), primarily due to the company's new key R&D projects, recruitment of high-end R&D personnel leading to increased compensation expenses, and increased R&D material investment and instrument depreciation costs[12] Shareholder Information Total Number of Common Shareholders, Number of Preferred Shareholders with Restored Voting Rights, and Top Ten Shareholders' Shareholding Status As of the end of the reporting period, the company had 3,961 common shareholders, with the top two shareholders, Beijing LabTech Management Consulting Co., Ltd. and LabTech Holdings, Inc., holding nearly 60% of shares, both controlled by the actual controller, Mr. Hu Ke Top Ten Shareholders' Shareholding Status | Shareholder Name | Nature | Shareholding Ratio (%) | Number of Shares | | :--- | :--- | :--- | :--- | | Beijing LabTech Management Consulting Co., Ltd. | Domestic Non-State Legal Person | 35.96 | 24,177,000 | | LabTech Holdings, Inc. | Overseas Legal Person | 23.97 | 16,118,000 | | Yu Hao | Domestic Natural Person | 2.13 | 1,432,446 | | Wang Yi | Domestic Natural Person | 1.80 | 1,210,084 | | Zhou Yixia | Domestic Natural Person | 1.47 | 985,718 | - As of the end of the reporting period, the company had a total of 3,961 common shareholders[14] - Major shareholder related party relationship: Beijing LabTech Management Consulting Co., Ltd. and LabTech Holdings, Inc. are both controlled by the company's actual controller, Hu Ke, forming a concerted action party[15] Quarterly Financial Statements Consolidated Balance Sheet As of September 30, 2023, the company's total assets were 993 million RMB, a 3.24% increase from the end of the previous year, with total liabilities at 144 million RMB, and owner's equity attributable to the parent company at 849 million RMB Balance Sheet Key Items (Unit: RMB) | Item | September 30, 2023 | December 31, 2022 | Change Rate | | :--- | :--- | :--- | :--- | | Cash and Bank Balances | 360,902,020.11 | 372,840,403.11 | -3.20% | | Inventories | 177,715,677.03 | 156,211,160.24 | +13.77% | | Fixed Assets | 148,536,316.13 | 138,552,579.34 | +7.21% | | Total Assets | 992,682,606.38 | 961,529,356.81 | +3.24% | | Contract Liabilities | 64,738,519.85 | 56,884,725.70 | +13.81% | | Total Liabilities | 143,634,816.05 | 134,852,233.51 | +6.51% | | Owner's Equity Attributable to Parent Company | 849,047,790.33 | 826,677,123.30 | +2.71% | Consolidated Income Statement In the first three quarters of 2023, the company achieved operating revenue of 300 million RMB, a 20.45% year-over-year increase, but net profit attributable to parent company shareholders declined by 22.77% due to faster growth in costs and expenses 2023 YTD Income Statement Key Items (Unit: RMB) | Item | 2023 YTD | 2022 YTD | YoY Change | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 299,949,773.52 | 249,029,652.65 | +20.45% | | Operating Cost | 166,250,340.66 | 127,128,861.33 | +30.77% | | Selling Expenses | 52,695,236.03 | 41,943,636.29 | +25.63% | | Administrative Expenses | 22,206,457.37 | 18,325,867.20 | +21.18% | | R&D Expenses | 36,857,433.66 | 26,960,651.01 | +36.71% | | Operating Profit | 26,393,003.74 | 38,845,360.09 | -32.06% | | Net Profit Attributable to Parent Company | 26,660,681.40 | 34,522,516.63 | -22.77% | | Basic Earnings Per Share | 0.40 | 0.51 | -21.57% | Consolidated Cash Flow Statement In the first three quarters of 2023, net cash flow from operating activities significantly improved to 15.77 million RMB from a net outflow in the prior year, primarily driven by increased cash received from sales 2023 YTD Cash Flow Statement Key Items (Unit: RMB) | Item | 2023 YTD | 2022 YTD | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 15,767,147.36 | -15,285,465.54 | | Net Cash Flow from Investing Activities | -17,548,539.70 | -122,127,608.34 | | Net Cash Flow from Financing Activities | -12,806,073.96 | -19,766,642.13 | | Net Increase in Cash and Cash Equivalents | -11,302,599.11 | -146,374,428.20 | | Cash and Cash Equivalents at End of Period | 360,201,276.47 | 348,171,551.13 | - The improvement in operating cash flow is mainly due to cash received from sales of goods and services increasing from 273 million RMB to 332 million RMB, a 21.6% year-over-year increase[26]